Drug Profile
Diabetes gene therapy - Pfizer/
Latest Information Update: 19 Jul 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source; Pfizer
- Class Diabetes gene therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus